APCO WORLDWIDE LLC

Lobbying for HIKMA PHARMACEUTICALS USA INC. · Pharmaceutical manufacturer

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $40,000.00 income · posted Jan 15, 2026

Lobbying activity 2

Health Issues

Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues

Trade (domestic/foreign)

Trade policies impacting domestic generic pharmaceutical manufacturing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.